Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conrad Leonard

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Plos One|January 11, 2018
Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencingAnn-Marie Patch, Katia Nones, Stephen H Kazakoff, et al.
Genome Medicine|April 30, 2017
Lost in translation: returning germline genetic results in genome-scale cancer researchAmber L Johns, Skye H McKay, Jeremy L Humphris, et al.
Biotechniques|July 10, 2014
A workflow to increase verification rate of chromosomal structural rearrangements using high-throughput next-generation sequencingKelly Quek, Katia Nones, Ann-Marie Patch, et al.
Cancers|February 24, 2024
Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel SequencingDavid Fielding, Vanessa Lakis, Andrew J Dalley, et al.
International Journal of Cancer|September 5, 2018
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibilityJames S Wilmott, Peter A Johansson, Felicity Newell, et al.
Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.
Cancer Cell|December 24, 2021
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordanceFelicity Newell, Ines Pires da Silva, Peter A Johansson, et al.
Cancer Cell|February 7, 2025
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordanceFelicity Newell, Ines Pires da Silva, Peter A Johansson, et al.
Plos One|November 20, 2013
Somatic point mutation calling in low cellularity tumorsKarin S Kassahn, Oliver Holmes, Katia Nones, et al.
Genome Medicine|March 18, 2026
Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunitiesKatia Nones, Vanessa Lakis, Andrew J Dalley, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Plos One|January 11, 2018
Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencingAnn-Marie Patch, Katia Nones, Stephen H Kazakoff, et al.
Genome Medicine|April 30, 2017
Lost in translation: returning germline genetic results in genome-scale cancer researchAmber L Johns, Skye H McKay, Jeremy L Humphris, et al.
Biotechniques|July 10, 2014
A workflow to increase verification rate of chromosomal structural rearrangements using high-throughput next-generation sequencingKelly Quek, Katia Nones, Ann-Marie Patch, et al.
Cancers|February 24, 2024
Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel SequencingDavid Fielding, Vanessa Lakis, Andrew J Dalley, et al.
International Journal of Cancer|September 5, 2018
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibilityJames S Wilmott, Peter A Johansson, Felicity Newell, et al.
Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.
Cancer Cell|December 24, 2021
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordanceFelicity Newell, Ines Pires da Silva, Peter A Johansson, et al.
Cancer Cell|February 7, 2025
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordanceFelicity Newell, Ines Pires da Silva, Peter A Johansson, et al.
Plos One|November 20, 2013
Somatic point mutation calling in low cellularity tumorsKarin S Kassahn, Oliver Holmes, Katia Nones, et al.
Genome Medicine|March 18, 2026
Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunitiesKatia Nones, Vanessa Lakis, Andrew J Dalley, et al.
Pageof 4